192 related articles for article (PubMed ID: 3718082)
21. Biochemical and antiarrhythmic effects of three calcium channel antagonists in ischemic canine hearts.
Ito T; Ogawa T; Satake T; Hieda N; Sugiyama S; Ozawa T
Clin Ther; 1989; 11(4):461-71. PubMed ID: 2776164
[TBL] [Abstract][Full Text] [Related]
22. Effects of a new calcium antagonist, CD-832, on isoproterenol-induced myocardial ischemia in dogs with partial coronary stenosis.
Takahashi T; Takahashi K; Kishi-Tanikawa S; Tsuchida K; Araki H; Higuchi S
J Pharmacol Exp Ther; 1996 Sep; 278(3):1028-33. PubMed ID: 8819482
[TBL] [Abstract][Full Text] [Related]
23. Effects of nicorandil and other antianginal drugs on myocardial pH in the ischemic dog heart.
Abiko Y; Ichihara K; Sakai K
J Cardiovasc Pharmacol; 1987; 10 Suppl 8():S85-91. PubMed ID: 2447430
[TBL] [Abstract][Full Text] [Related]
24. Comparative effects of two slow channel calcium entry blockers, FR 34235 and nifedipine, on true coronary collateral blood flow.
Gross GJ; Warltier DC; Hardman HF
J Cardiovasc Pharmacol; 1984; 6(1):61-7. PubMed ID: 6199613
[TBL] [Abstract][Full Text] [Related]
25. Effects of KB-944, a novel calcium antagonist, in several models of canine myocardial ischemia.
Pelc LR; Gross GJ; Warltier DC
J Pharmacol Exp Ther; 1986 Jul; 238(1):113-8. PubMed ID: 3723394
[TBL] [Abstract][Full Text] [Related]
26. [Effects of dichloroacetate in the ischemic heart. Analysis of hemodynamics, myocardial energy metabolism and myocardial pH].
Mizushima M
Hokkaido Igaku Zasshi; 1990 May; 65(3):298-310. PubMed ID: 2379912
[TBL] [Abstract][Full Text] [Related]
27. [Underlying mechanism of favorable effect of Ca++-antagonists on conduction delay observed in ischemic myocardium (author's transl)].
Nakaya H
Hokkaido Igaku Zasshi; 1981 May; 56(3):335-45. PubMed ID: 7319455
[TBL] [Abstract][Full Text] [Related]
28. Differential effects of intravenous vs. intracoronary nifedipine on myocardial segment function in ischemic canine hearts.
Lamping KA; Gross GJ
J Pharmacol Exp Ther; 1984 Jan; 228(1):28-32. PubMed ID: 6694108
[TBL] [Abstract][Full Text] [Related]
29. Effects of the new dihydropyridine derivative 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic acid methyl 6-(5-phenyl-3-pyrazolyloxy)hexyl ester on the cardiohemodynamics and the energy metabolism of ischemic myocardium.
Imai H; Matsui K; Ochi S; Nakazawa M; Nakagawa Y; Imai S
Arzneimittelforschung; 1987 Dec; 37(12):1348-52. PubMed ID: 3449062
[TBL] [Abstract][Full Text] [Related]
30. Effects of nicorandil, a new antianginal agent, and nifedipine on collateral blood flow in a chronic coronary occlusion model.
Lamping KA; Warltier DC; Hardman HF; Gross GJ
J Pharmacol Exp Ther; 1984 May; 229(2):359-63. PubMed ID: 6232374
[TBL] [Abstract][Full Text] [Related]
31. Comparative coronary vasodilatory effects of nifedipine and niludipine.
Ogawa K; Wakamasu Y; Ito T; Suzuki T; Yamazaki N
Arzneimittelforschung; 1981; 31(5):770-3. PubMed ID: 7196733
[TBL] [Abstract][Full Text] [Related]
32. [Protective effect of nicardipine hydrochloride on the perfused ischemic canine myocardium].
Sunamori M; Okamura T; Amano J; Suzuki A
Kokyu To Junkan; 1983 Nov; 31(11):1241-4. PubMed ID: 6676796
[No Abstract] [Full Text] [Related]
33. Coronary collateral blood flow in acute myocardial ischemia is not increased by dihydropyridine-induced coronary vasodilatation.
Sjöquist PO; Duker G; Almgren O
J Cardiovasc Pharmacol; 1985; 7(4):630-6. PubMed ID: 2410700
[TBL] [Abstract][Full Text] [Related]
34. Protection of the ischemic myocardium with calcium antagonistic drugs.
Yamasawa I; Nohara Y; Konno S; Nagai Y; Yaoita N; Kaneko Y; Takahashi H; Takanashi M; Abe T; Hachiya T; Sassa H
Arzneimittelforschung; 1983; 33(3):389-96. PubMed ID: 6683512
[TBL] [Abstract][Full Text] [Related]
35. Effect of verapamil and nifedipine on ischemic myocardial metabolism in dogs.
Ichihara K; Ichihara M; Abiko Y
Arzneimittelforschung; 1979; 29(10):1539-44. PubMed ID: 583218
[TBL] [Abstract][Full Text] [Related]
36. Effects of calcium entry blockers on coronary constriction and myocardial ischemia due to leukotriene D4.
Ezra D; Boyd LM; Goldstein RE; Feuerstein G
J Pharmacol Exp Ther; 1985 Apr; 233(1):229-34. PubMed ID: 3981457
[TBL] [Abstract][Full Text] [Related]
37. MCl-176, a novel calcium channel blocker, attenuates the ischemic myocardial acidosis induced by coronary artery occlusion in dogs.
Hara Y; Ichihara K; Abiko Y
J Pharmacol Exp Ther; 1988 Apr; 245(1):305-10. PubMed ID: 3361449
[TBL] [Abstract][Full Text] [Related]
38. Chronotropic, inotropic, and vasodilator actions of diltiazem, nifedipine, and verapamil. A comparative study of physiological responses and membrane receptor activity.
Millard RW; Grupp G; Grupp IL; DiSalvo J; DePover A; Schwartz A
Circ Res; 1983 Feb; 52(2 Pt 2):I29-39. PubMed ID: 6831652
[TBL] [Abstract][Full Text] [Related]
39. Vasodilating effects of the new calcium antagonist benidipine hydrochloride in anesthetized dogs and cats.
Karasawa A; Kubo K; Shuto K; Oka T; Nakamizo N
Arzneimittelforschung; 1988 Nov; 38(11A):1707-12. PubMed ID: 3219145
[TBL] [Abstract][Full Text] [Related]
40. Attenuation by isosorbide dinitrate of coronary occlusion-induced acidosis in the dog myocardium.
Abiko Y; Fukushi Y; Haga N; Matsumura H
Br J Pharmacol; 1986 Feb; 87(2):427-32. PubMed ID: 3955308
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
